Alydia Health

Alydia Health is dedicated to preventing maternal morbidity and mortality caused by postpartum hemorrhage (PPH) and abnormal postpartum uterine bleeding. Its investigational device, the Jada System, is designed to work with the uterus's natural contractions to quickly stop excessive bleeding after childbirth. Alydia's Jada System is intended to assist the uterus in contracting normally to prevent heavy bleeding after delivery. Based on the results of the company’s pivotal PEARLE IDE study, Alydia received FDA 510(k) clearance (marketing authorization) for the Jada System in August 2020.